Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammation mediator modulation refers to the regulation of molecules—known as inflammatory mediators—that are released by immune and other cells in response to injury, infection, or harmful stimuli. These mediators play a central role in initiating, amplifying, and resolving inflammation by affecting vascular permeability, recruiting immune cells, and orchestrating tissue repair or damage. Key examples include cytokines like IL-1β, IL-6, and TNF-α, eicosanoids like prostaglandins, thromboxanes, and leukotrienes, vasoactive amines like histamine, and acute-phase proteins. Modulation mechanisms involve pro- and anti-inflammatory cytokines, and lipid mediator pathways. This modulation is fundamental for host defense and implicated in diseases like cardiovascular disease, diabetes, autoimmune disorders, and cancer progression.
Regulation of inflammatory mediators through receptor-mediated signaling, impacting gene expression and subsequent release or action of mediators.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammation Mediator Modulation.